Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

Anita V Mitra, Elizabeth K Bancroft, Yolanda Barbachano, Elizabeth C Page, C S Foster, C Jameson, G Mitchell, G J Lindeman, A Stapleton, G Suthers, D G Evans, D Cruger, I Blanco, C Mercer, J Kirk, L Maehle, S Hodgson, L Walker, L Izatt, F DouglasK Tucker, H Dorkins, V Clowes, A Male, A Donaldson, C Brewer, R Doherty, B Bulman, P J Osther, M Salinas, D Eccles, K Axcrona, I Jobson, B Newcombe, C Cybulski, W S Rubinstein, S Buys, S Townshend, E Friedman, S Domchek, T Ramon Y Cajal, A Spigelman, S H Teo, N Nicolai, N Aaronson, A Ardern-Jones, C Bangma, D Dearnaley, J Eyfjord, A Falconer, H Grönberg, F Hamdy, O Johannsson, V Khoo, Z Kote-Jarai, H Lilja, J Lubinski, J Melia, C Moynihan, S Peock, G Rennert, F Schröder, P Sibley, M Suri, P Wilson, Y J Bignon, S Strom, M Tischkowitz, A Liljegren, D Ilencikova, A Abele, K Kyriacou, C van Asperen, L Kiemeney, D F Easton, Rosalind A Eeles

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology